BACKGROUND: Major depression (MDD) is characterized by altered emotion processing and deficits in cognitive control. In cognitive interference tasks, patients with MDD have shown excessive amygdala activity and under-recruitment of dorsolateral prefrontal cortex (DLPFC). The purpose of this study was to examine the effects of antidepressant treatment on anomalous neural activity in cognitive-control and emotion-processing circuitry. METHODS: Functional magnetic resonance imaging was conducted on depressed patients (n=23) (both before and after antidepressant treatment) compared with matched controls (n=18) while they performed a cognitive task involving attended and unattended fear-related stimuli. RESULTS: After eight weeks of SSRI antidepressant treatment, patients with depression showed significantly increased DLPFC activity to unattended fear-related stimuli and no longer differed from controls in either DLPFC or amygdala activity. CONCLUSIONS: These results suggest that antidepressant treatment increases DLPFC under-activity during cognitive tasks that include emotional interference. LIMITATIONS: The sample was fairly homogeneous and this may limit generalizability.
BACKGROUND: Major depression (MDD) is characterized by altered emotion processing and deficits in cognitive control. In cognitive interference tasks, patients with MDD have shown excessive amygdala activity and under-recruitment of dorsolateral prefrontal cortex (DLPFC). The purpose of this study was to examine the effects of antidepressant treatment on anomalous neural activity in cognitive-control and emotion-processing circuitry. METHODS: Functional magnetic resonance imaging was conducted on depressedpatients (n=23) (both before and after antidepressant treatment) compared with matched controls (n=18) while they performed a cognitive task involving attended and unattended fear-related stimuli. RESULTS: After eight weeks of SSRI antidepressant treatment, patients with depression showed significantly increased DLPFC activity to unattended fear-related stimuli and no longer differed from controls in either DLPFC or amygdala activity. CONCLUSIONS: These results suggest that antidepressant treatment increases DLPFC under-activity during cognitive tasks that include emotional interference. LIMITATIONS: The sample was fairly homogeneous and this may limit generalizability.
Authors: H S Mayberg; M Liotti; S K Brannan; S McGinnis; R K Mahurin; P A Jerabek; J A Silva; J L Tekell; C C Martin; J L Lancaster; P T Fox Journal: Am J Psychiatry Date: 1999-05 Impact factor: 18.112
Authors: S H Kennedy; K R Evans; S Krüger; H S Mayberg; J H Meyer; S McCann; A I Arifuzzman; S Houle; F J Vaccarino Journal: Am J Psychiatry Date: 2001-06 Impact factor: 18.112
Authors: Deanna M Barch; Michael S Gaffrey; Kelly N Botteron; Andrew C Belden; Joan L Luby Journal: Biol Psychiatry Date: 2012-07-07 Impact factor: 13.382
Authors: Rebecca Kerestes; Zubin Bhagwagar; Pradeep J Nathan; Shashwath A Meda; Cecile D Ladouceur; Kathleen Maloney; David Matuskey; Barbara Ruf; Aybala Saricicek; Fei Wang; Godfrey D Pearlson; Mary L Phillips; Hilary P Blumberg Journal: Psychiatry Res Date: 2012-05-16 Impact factor: 3.222
Authors: Brittany M Thompson; Michael V Baratta; Joseph C Biedenkapp; Jerry W Rudy; Linda R Watkins; Steven F Maier Journal: Learn Mem Date: 2010-11-01 Impact factor: 2.460
Authors: Jonathan Posner; David J Hellerstein; Inbal Gat; Anna Mechling; Kristin Klahr; Zhishun Wang; Patrick J McGrath; Jonathan W Stewart; Bradley S Peterson Journal: JAMA Psychiatry Date: 2013-04 Impact factor: 21.596